An updated meta-analysis of the association between ADIPOQ rs2241766 polymorphism and colorectal cancer

Peto J. Cancer epidemiology in the last century and the next decade. Nature. 2001;411(6835):390–5.

Parkin DM et al. Global cancer statistics. CA Cancer J Clin. 2005;55(2):74–108.

Fearon ER. Human cancer syndromes: clues to the origin and nature of cancer. Science. 1997;278(5340):1043–50.

Risch N. The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev. 2001;10(7):733–41.

Lichtenstein P et al. Environmental and heritable factors in the causation of cancer–analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343(2):78–85.

Pischon T et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2006;98(13):920–31.

Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr. 2007;86(3):556–65.

Housa D et al. Adipocytokines and cancer. Physiol Res. 2006;55(3):233–44.

Huang XF, Chen JZ. Obesity, the PI3K/Akt signal pathway and colon cancer. Obes Rev. 2009;10(6):610–6.

Drew JE et al. Insulin, leptin, and adiponectin receptors in colon: regulation relative to differing body adiposity independent of diet and in response to dimethylhydrazine. Am J Physiol Gastrointest Liver Physiol. 2007;293(4):G682–91.

Williams CJ et al. Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors. Endocr Relat Cancer. 2008;15(1):289–99.

Wei EK et al. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst. 2005;97(22):1688–94.

Sherry ST et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29(1):308–11.

Menzaghi C et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes. 2002;51(7):2306–12.

Yang WS et al. Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity. J Mol Med (Berl). 2003;81(7):428–34.

Kaklamani VG et al. Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA. 2008;300(13):1523–31.

Partida-Perez M et al. Association of LEP and ADIPOQ common variants with colorectal cancer in Mexican patients. Cancer Biomark. 2010;7(3):117–21.

He B et al. Effects of genetic variations in the adiponectin pathway genes on the risk of colorectal cancer in the Chinese population. BMC Med Genet. 2011;12:94.

Zhang Y, Feng QL, Liu CM, et al. Relationship between polymorphism sites of adiponection and it’s receptor gene and the susceptibility of colorectal cancer. Jiangsu Daxue Xuebao (Medical Edition). 2012;22:336–41.

Liu, L., Adiponectin and leptin gene families with colorectal cancer-study on susceptibility and progression of disease. Dissertation. Huazhong University of Science and Technology, 2012

Al-Harithy RN, Al-Zahrani MH. The adiponectin gene, ADIPOQ, and genetic susceptibility to colon cancer. Oncol Lett. 2012;3(1):176–80.

Hu X et al. Gene Polymorphisms of +45T>G, −866G>A, and ala54thr on the risk of colorectal cancer: a matched case–control study. PLoS One. 2013;8(6):e67275.

Xu Y et al. The roles of ADIPOQ genetic variations in cancer risk: evidence from published studies. Mol Biol Rep. 2013;40(2):1135–44.

Ye C et al. Meta-analysis of adiponectin polymorphisms and colorectal cancer risk. Int J Med Sci. 2013;10(9):1113–20.

Zhou W, Liu Y, Zhong DW. Adiponectin (ADIPOQ) rs2241766 G/T polymorphism is associated with risk of cancer: evidence from a meta-analysis. Tumour Biol. 2013;34(1):493–504.

Cochran W. The combination of estimates from different experiments. Biometrics. 1954;10(1):101–29.

Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.

Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–48.

DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.

Egger M et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.

Beebe-Dimmer JL et al. Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans. Prostate Cancer Prostatic Dis. 2010;13(4):362–8.

Teras LR et al. No association between polymorphisms in LEP, LEPR, ADIPOQ, ADIPOR1, or ADIPOR2 and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2009;18(9):2553–7.

Pechlivanis S et al. Genetic variation in adipokine genes and risk of colorectal cancer. Eur J Endocrinol. 2009;160(6):933–40.